The pharmaceutical industry has experienced a groundbreaking advancement in diabetes management with the introduction of copyright. This innovative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to regulating blood sugar levels in individuals with type 2 diabetes. copyright functions by simulat